EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 22015D2134
Decision of the EEA Joint Committee No 267/2014 of 12 December 2014 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2015/2134]
Decision of the EEA Joint Committee No 267/2014 of 12 December 2014 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2015/2134]
Decision of the EEA Joint Committee No 267/2014 of 12 December 2014 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2015/2134]
OJ L 311, 26.11.2015, p. 17–18
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
|
26.11.2015 |
EN |
Official Journal of the European Union |
L 311/17 |
DECISION OF THE EEA JOINT COMMITTEE
No 267/2014
of 12 December 2014
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2015/2134]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Decision 2014/397/EU of 25 June 2014 postponing the expiry date of approval of difethialone and difenacoum for use in biocidal products for product-type 14 (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Commission Implementing Decision 2014/402/EU of 25 June 2014 regarding restrictions of authorisations of biocidal products containing IPBC notified by Germany in accordance with Directive 98/8/EC of the European Parliament and of the Council (2) is to be incorporated into the EEA Agreement. |
|
(3) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
The following points are inserted after point 12nna (Commission Delegated Regulation (EU) No 492/2014) of Chapter XV of Annex II to the EEA Agreement:
|
‘12nnb. |
32014 D 0397: Commission Implementing Decision 2014/397/EU of 25 June 2014 postponing the expiry date of approval of difethialone and difenacoum for use in biocidal products for product-type 14 (OJ L 186, 26.6.2014, p. 111). |
|
12nnc. |
32014 D 0402: Commission Implementing Decision 2014/402/EU of 25 June 2014 regarding restrictions of authorisations of biocidal products containing IPBC notified by Germany in accordance with Directive 98/8/EC of the European Parliament and of the Council (OJ L 188, 27.6.2014, p. 85).’ |
Article 2
The texts of Implementing Decisions 2014/397/EU and 2014/402/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 13 December 2014, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (3).
For Liechtenstein, this Decision shall enter into force on the same day or on the day of entry into force of the Agreement between Liechtenstein and Switzerland laying down the cooperation in the field of authorisation procedures for biocidal products according to Regulation (EU) No 528/2012 of the European Parliament and of the Council (4), whichever is the later.
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 12 December 2014.
For the EEA Joint Committee
The President
Kurt JÄGER
(1) OJ L 186, 26.6.2014, p. 111.
(2) OJ L 188, 27.6.2014, p. 85.
(3) No constitutional requirements indicated.
(4) Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (OJ L 167, 27.6.2012, p. 1).